FBN1 and Marfan syndrome: The mutations, c.4942 + 2 T > C and c.4817-2delA were associated with 72 % and 80 % of FBN1 mRNA expression compared to controls, respectively, and the patients were severely affected with several major, including major cardiovascular, manifestations of MFS (Table 1).